PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.520.06 (-1.08%)
5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.35%
Revenue growth at 75-90% of STERV.HE's 5.71%. Bill Ackman would push for innovation or market expansion to catch up.
12.82%
Positive gross profit growth while STERV.HE is negative. John Neff would see a clear operational edge over the competitor.
27.13%
Positive EBIT growth while STERV.HE is negative. John Neff might see a substantial edge in operational management.
27.13%
Positive operating income growth while STERV.HE is negative. John Neff might view this as a competitive edge in operations.
27.59%
Positive net income growth while STERV.HE is negative. John Neff might see a big relative performance advantage.
121.43%
Positive EPS growth while STERV.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
121.43%
Positive diluted EPS growth while STERV.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.96%
Slight or no buybacks while STERV.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.96%
Slight or no buyback while STERV.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-79.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-142.71%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-29.04%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
8.85%
Positive 5Y CAGR while STERV.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
1.36%
Positive 3Y CAGR while STERV.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-52.74%
Negative 10Y OCF/share CAGR while STERV.HE stands at 981.97%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
172.35%
Positive OCF/share growth while STERV.HE is negative. John Neff might see a comparative advantage in operational cash viability.
-43.77%
Negative 3Y OCF/share CAGR while STERV.HE stands at 4.76%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
121.16%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
152.75%
5Y net income/share CAGR above 1.5x STERV.HE's 22.03%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
17.95%
Positive short-term CAGR while STERV.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
40.04%
10Y equity/share CAGR in line with STERV.HE's 37.84%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
41.47%
5Y equity/share CAGR at 50-75% of STERV.HE's 58.35%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
28.79%
3Y equity/share CAGR at 50-75% of STERV.HE's 41.79%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.14%
AR growth well above STERV.HE's 7.51%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.18%
Inventory growth well above STERV.HE's 11.36%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.64%
Positive asset growth while STERV.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
12.97%
Positive BV/share change while STERV.HE is negative. John Neff sees a clear edge over a competitor losing equity.
2.86%
We have some new debt while STERV.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-49.54%
We cut SG&A while STERV.HE invests at 9.14%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.